• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

China - COVID-19 cases up in Guangdong province in July - August 12, 2024

sharon sanders

Editor-in-Chief & President
For trend only. China's actual disease numbers are highly suspect. Reported only 2 COVID-19 related deaths in a surge situation, in a country of approximately 1.4 billion people.

Guangdong's new crown infection cases increased by more than 10,000 cases per month! New crown special medicine concept stocks exploded, and Guangshengtang rose by 20%!

August 12, 2024 10:51


  On Monday, A-shares generally opened lower, with the Shanghai Composite Index down 0.15%, the Shenzhen Component Index down 0.03%, and the ChiNext Index up 0.02%. On the market, COVID-19 testing, wind power, photovoltaic inverters, and lithium batteries were strong.
  On August 12, concept stocks of special COVID-19 drugs exploded, with Guangshengtang rising by 20%, Shutaishen rising by more than 15%, Hongri Pharmaceutical rising by more than 12%, and Yiling Pharmaceutical rising by 10%.

  On August 12, Daan Gene and Kehua Bio both hit their daily limit, Mike Biotech rose more than 7%, and Mingde Biopharma and BGI also soared.

  On the news front, the World Health Organization warned at a press conference in Geneva that data from more than 80 countries showed that the number of people infected with the main pathogen of the new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has continued to increase in recent days.
  According to the national novel coronavirus epidemic situation in July released by the Chinese Center for Disease Control and Prevention, from July 1 to July 31, 31 provinces (autonomous regions, municipalities) and the Xinjiang Production and Construction Corps reported 203 new severe cases and 2 deaths (including 0 deaths due to respiratory failure caused by novel coronavirus infection and 2 deaths due to underlying diseases combined with novel coronavirus infection).
  It is worth noting that the positive rate of COVID-19 in influenza-like cases continued to rise from 8.9% in the 27th week (July 1st to July 7th) to 18.7% in the 30th week (July 22nd to July 28th). In other words, COVID-19 infection is on the rise.
  Showing the same trend, the Guangdong Provincial Centers for Disease Control and Prevention published an overview of the province's statutory infectious disease epidemics in June and July 2024, showing that the number of new coronavirus infections in Guangdong Province was 8,246 in June and 18,384 in July, an increase of more than 10,000 cases.

  However, as a sentinel hospital for monitoring influenza-like cases in children across the province, Yin Genquan, chief pediatrician at the Guangzhou Women and Children's Medical Center, said that no signs of an increase in children's COVID-19 infection have been found in the outpatient clinic. Professor Han Zitian, co-director of the Large-Scale Respiratory Disease Epidemic Forecasting and Early Warning and Medical Big Data Artificial Intelligence Application Laboratory, said: "From observation, this is a normal peak of COVID-19 infection. There is not much change, so there is no need to worry."

  The number of cases is rising, so has the virus mutated? According to information released by the Chinese Center for Disease Control and Prevention, compared with June, the effective genome sequences of the new coronavirus in local cases in my country in July were all Omicron variants, and the main prevalent strains were JN.1 series variants and XDV series variants.
  The reporter saw that the proportion of XDV series variants increased from 25.1% to 32.9% in June to 38.8% to 43.6% in July, an increase of about 10%. "Don't be nervous, the current new coronavirus is not that virulent." Yin Genquan believes that the pathogenicity of the virus has been greatly reduced, and the public does not need to worry.
  This has also been recognized by respiratory experts. Yan Wensen, deputy chief physician of the Department of Respiratory and Critical Care Medicine at Guangdong Provincial Second People's Hospital, told reporters: "Recently, we occasionally encounter new coronavirus patients in the outpatient clinic. The symptoms are relatively mild, mainly young people, and most of them have symptoms such as sore throat, fever, and muscle aches. Moreover, the cases are often sporadic, without obvious family clustering. This also shows that the virus is less contagious."



zhttps://news.sina.com.cn/c/2024-08-12/doc-incikerh2581100.shtml?cre=tianyi&mod=pcpager_news&loc=12&r=0&rfunc=64&tj=cxvertical_pc_pager_news&tr=174

 
Back
Top